Sweden · Delayed Price · Currency is SEK AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 143.01 million. The enterprise value is 108.94 million.
| Market Cap | 143.01M |
| Enterprise Value | 108.94M |
Important Dates
The last earnings date was Friday, November 14, 2025.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 234.44 million shares outstanding. The number of shares has increased by 71.40% in one year.
| Current Share Class | 234.44M |
| Shares Outstanding | 234.44M |
| Shares Change (YoY) | +71.40% |
| Shares Change (QoQ) | +5.83% |
| Owned by Insiders (%) | 0.46% |
| Owned by Institutions (%) | -0.82% |
| Float | 233.35M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 16.58 |
| PB Ratio | 2.03 |
| P/TBV Ratio | 2.14 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.04 |
| EV / Sales | 12.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.28
| Current Ratio | 8.28 |
| Quick Ratio | 8.15 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -230.57 |
Financial Efficiency
Return on equity (ROE) is -45.18% and return on invested capital (ROIC) is -28.52%.
| Return on Equity (ROE) | -45.18% |
| Return on Assets (ROA) | -26.99% |
| Return on Invested Capital (ROIC) | -28.52% |
| Return on Capital Employed (ROCE) | -38.59% |
| Revenue Per Employee | 2.16M |
| Profits Per Employee | -6.73M |
| Employee Count | 4 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.21% in the last 52 weeks. The beta is 1.32, so AcuCort AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | -16.21% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 0.69 |
| Relative Strength Index (RSI) | 51.75 |
| Average Volume (20 Days) | 297,662 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 8.63 million and -26.93 million in losses. Loss per share was -0.16.
| Revenue | 8.63M |
| Gross Profit | -12.02M |
| Operating Income | -27.21M |
| Pretax Income | -26.93M |
| Net Income | -26.93M |
| EBITDA | n/a |
| EBIT | -27.21M |
| Loss Per Share | -0.16 |
Balance Sheet
The company has 34.08 million in cash and n/a in debt, giving a net cash position of 34.08 million or 0.15 per share.
| Cash & Cash Equivalents | 34.08M |
| Total Debt | n/a |
| Net Cash | 34.08M |
| Net Cash Per Share | 0.15 |
| Equity (Book Value) | 70.50M |
| Book Value Per Share | 0.30 |
| Working Capital | 30.79M |
Cash Flow
| Operating Cash Flow | -14.66M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -139.38% |
| Operating Margin | -315.41% |
| Pretax Margin | -312.21% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -71.40% |
| Shareholder Yield | -71.40% |
| Earnings Yield | -18.83% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 17.27 and a Piotroski F-Score of 2.
| Altman Z-Score | 17.27 |
| Piotroski F-Score | 2 |